Go Pro

OMERS ADMINISTRATION Corp Makes New $4.04 Million Investment in Cigna Group $CI

Cigna Group logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • OMERS Administration Corp. acquired 14,641 Cigna shares worth approximately $4.04 million in the second quarter. Institutional investors collectively own 86.99% of Cigna’s outstanding stock.
  • Cigna reported quarterly adjusted earnings of $7.78 per share, beating estimates of $7.60, while revenue rose 6.7% year over year to $70.04 billion. The company maintained full-year 2026 earnings guidance near $30.45 per share.
  • Cigna declared a quarterly dividend of $1.56 per share, equivalent to a 2.2% annualized yield. Analysts maintain a “Moderate Buy” consensus rating with an average price target of $339.45, above the reported share price of $279.24.
  • MarketBeat previews top five stocks to own in September.

OMERS ADMINISTRATION Corp acquired a new position in shares of Cigna Group (NYSE:CI - Free Report) in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The fund acquired 14,641 shares of the health services provider's stock, valued at approximately $4,036,000.

Other hedge funds have also recently modified their holdings of the company. Evercore Wealth Management LLC lifted its position in Cigna Group by 2.8% in the first quarter. Evercore Wealth Management LLC now owns 1,301 shares of the health services provider's stock valued at $347,000 after acquiring an additional 35 shares during the last quarter. Cary Street Partners Investment Advisory LLC grew its holdings in shares of Cigna Group by 11.0% during the fourth quarter. Cary Street Partners Investment Advisory LLC now owns 363 shares of the health services provider's stock worth $100,000 after purchasing an additional 36 shares during the last quarter. IHT Wealth Management LLC increased its position in shares of Cigna Group by 2.5% during the fourth quarter. IHT Wealth Management LLC now owns 1,535 shares of the health services provider's stock worth $423,000 after purchasing an additional 38 shares in the last quarter. Whetstone Capital Advisors LLC lifted its holdings in shares of Cigna Group by 4.9% in the 4th quarter. Whetstone Capital Advisors LLC now owns 829 shares of the health services provider's stock valued at $228,000 after purchasing an additional 39 shares during the last quarter. Finally, CYBER HORNET ETFs LLC boosted its position in shares of Cigna Group by 5.3% in the 4th quarter. CYBER HORNET ETFs LLC now owns 801 shares of the health services provider's stock valued at $220,000 after purchasing an additional 40 shares during the period. 86.99% of the stock is owned by hedge funds and other institutional investors.

Cigna Group Stock Performance

NYSE CI opened at $279.24 on Wednesday. The firm has a market cap of $73.79 billion, a P/E ratio of 11.55, a P/E/G ratio of 0.96 and a beta of 0.29. Cigna Group has a 52-week low of $239.51 and a 52-week high of $315.47. The business's 50-day moving average price is $283.67 and its 200 day moving average price is $281.53. The company has a quick ratio of 0.76, a current ratio of 0.76 and a debt-to-equity ratio of 0.68.

Cigna Group (NYSE:CI - Get Free Report) last posted its quarterly earnings data on Thursday, July 30th. The health services provider reported $7.78 EPS for the quarter, beating the consensus estimate of $7.60 by $0.18. Cigna Group had a return on equity of 19.75% and a net margin of 2.27%.The firm had revenue of $70.04 billion during the quarter, compared to the consensus estimate of $70.14 billion. During the same period in the prior year, the business earned $7.20 EPS. The firm's revenue was up 6.7% compared to the same quarter last year. Cigna Group has set its FY 2026 guidance at 30.450- EPS. On average, equities research analysts expect that Cigna Group will post 30.51 earnings per share for the current year.

Cigna Group Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, September 23rd. Investors of record on Tuesday, September 8th will be issued a dividend of $1.56 per share. The ex-dividend date of this dividend is Tuesday, September 8th. This represents a $6.24 annualized dividend and a dividend yield of 2.2%. Cigna Group's dividend payout ratio (DPR) is currently 25.82%.

Wall Street Analyst Weigh In

A number of research analysts recently issued reports on the company. Cantor Fitzgerald raised their price target on Cigna Group from $325.00 to $340.00 and gave the stock an "overweight" rating in a research note on Friday, May 1st. Robert W. Baird set a $362.00 price objective on Cigna Group in a research note on Friday, July 31st. Royal Bank Of Canada increased their price objective on Cigna Group from $333.00 to $337.00 and gave the company an "outperform" rating in a report on Friday, May 1st. Guggenheim raised their target price on shares of Cigna Group from $338.00 to $361.00 and gave the stock a "buy" rating in a research report on Friday, July 31st. Finally, Weiss Ratings reaffirmed a "hold (c)" rating on shares of Cigna Group in a report on Monday, June 1st. Fifteen investment analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company. According to MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average target price of $339.45.

Check Out Our Latest Research Report on CI

Insiders Place Their Bets

In other news, CAO Jamie G. Kates sold 899 shares of the firm's stock in a transaction on Friday, June 12th. The shares were sold at an average price of $298.61, for a total value of $268,450.39. Following the completion of the sale, the chief accounting officer owned 2,368 shares in the company, valued at approximately $707,108.48. This trade represents a 27.52% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Nicole S. Jones sold 19,436 shares of the stock in a transaction dated Tuesday, August 4th. The stock was sold at an average price of $276.27, for a total transaction of $5,369,583.72. Following the transaction, the insider directly owned 27,256 shares of the company's stock, valued at $7,530,015.12. This represents a 41.63% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders sold 23,012 shares of company stock worth $6,386,550. 0.60% of the stock is currently owned by insiders.

Cigna Group Company Profile

(Free Report)

Cigna Group NYSE: CI is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

Recommended Stories

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CI - Free Report).

Institutional Ownership by Quarter for Cigna Group (NYSE:CI)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in Cigna Group Right Now?

Before you consider Cigna Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cigna Group wasn't on the list.

While Cigna Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 7 Hottest IPO Stories of 2026 Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines